CBT has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
CBT has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | No Debt |
CBT's Cash to Debt is ranked lower than
81% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.31 vs. CBT: No Debt ) |
CBT'
s 10-Year Cash to Debt Range
Min: 0.09 Max: No Debt Current: No Debt |
| Interest Coverage | 5.9 |
CBT's Interest Coverage is ranked lower than
77% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 10000.00 vs. CBT: 5.9 ) |
CBT'
s 10-Year Interest Coverage Range
Min: 5 Max: 9 Current: 5.9 |
| F-Score: 5 |
|
| Z-Score: 2.15 |
|
| M-Score: -2.45 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 8.50 |
CBT's Operating margin (%) is ranked higher than
60% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.30 vs. CBT: 8.50 ) |
CBT'
s 10-Year Operating margin (%) Range
Min: -3.6 Max: 13.1 Current: 8.5 |
| Net-margin (%) | 10.8 |
CBT's Net-margin (%) is ranked higher than
59% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 3.50 vs. CBT: 10.8 ) |
CBT'
s 10-Year Net-margin (%) Range
Min: -3.4 Max: 29.7 Current: 10.8 |
| Revenue Growth (%) | 3.7 |
CBT's Revenue Growth (%) is ranked higher than
94% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 3.50 vs. CBT: 3.7 ) |
CBT'
s 10-Year Revenue Growth (%) Range
Min: -1.2 Max: 12.7 Current: 3.7 |
| EBITDA Growth (%) | 3.7 |
CBT's EBITDA Growth (%) is ranked higher than
98% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.90 vs. CBT: 3.7 ) |
CBT'
s 10-Year EBITDA Growth (%) Range
Min: -26.1 Max: 47.5 Current: 3.7 |
| EPS Growth (%) | 24.5 |
CBT's EPS Growth (%) is ranked lower than
77% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 10.00 vs. CBT: 24.5 ) |
CBT'
s 10-Year EPS Growth (%) Range
Min: -34.5 Max: 27.8 Current: 24.5 |
| PRIMECAP Management 790,000 sh (New) Paul Tudor Jones 19,200 sh (New) Chuck Royce 2,537,790 sh (+24.24%) David Dreman 670,462 sh (+0.43%) | Steven Cohen 11,573 sh (-21.78%) |
| Joel Greenblatt 49,573 sh (New) Jim Simons 174,900 sh (New) PRIMECAP Management 990,000 sh (+25.32%) Paul Tudor Jones 20,600 sh (+7.29%) | Chuck Royce 2,537,790 sh (unchged) | David Dreman 653,285 sh (-2.56%) Steven Cohen 6,917 sh (-40.23%) |
| Jim Simons 284,300 sh (+62.55%) David Dreman 753,018 sh (+15.27%) Chuck Royce 2,726,630 sh (+7.44%) PRIMECAP Management 1,010,000 sh (+2.02%) | Steven Cohen Sold Out Joel Greenblatt Sold Out Paul Tudor Jones 5,100 sh (-75.24%) |
| Paul Tudor Jones 19,700 sh (+286.27%) Chuck Royce 3,052,430 sh (+11.95%) | Paul Singer 460,000 sh (unchged) PRIMECAP Management 1,010,000 sh (unchged) | David Dreman 746,188 sh (-0.91%) Jim Simons 29,300 sh (-89.69%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Joel Greenblatt | 2012-12-31 | Sold Out | 0.12% | $33.72 - $40.17 | $ 40.36 | 9% | 0 | |
| David Dreman | 2012-12-31 | Add 15.27% | 0.11% | $33.72 - $40.17 | $ 40.36 | 9% | 753018 | |
| Joel Greenblatt | 2012-09-30 | New Buy | 0.12% | $34.54 - $41.29 | $ 40.36 | 7% | 49573 | |
| PRIMECAP Management | 2012-09-30 | Add 25.32% | 0.01% | $34.54 - $41.29 | $ 40.36 | 7% | 990000 | |
| PRIMECAP Management | 2012-06-30 | New Buy | 0.05% | $35.55 - $44.66 | $ 40.36 | 1% | 790000 | |
| Ray Dalio | 2011-12-31 | Sold Out | 0.05% | $23.27 - $34 | $ 40.36 | 34% | 0 | |
| David Dreman | 2011-09-30 | New Buy | 0.45% | $24.88 - $42.8 | $ 40.36 | 16% | 727754 | |
| George Soros | 2011-06-30 | Sold Out | $37.45 - $47.83 | $ 40.36 | -4% | 0 | ||
| George Soros | 2011-03-31 | Reduce -85.87% | 0.06% | $37.65 - $46.58 | $ 40.36 | -6% | 9100 | |
| George Soros | 2010-12-31 | Add 387.88% | 0.02% | $32.59 - $38.72 | $ 40.36 | 14% | 64400 | |
| George Soros | 2010-09-30 | Reduce -95.13% | 0.2% | $23.37 - $32.97 | $ 40.36 | 39% | 13200 | |
| George Soros | 2010-06-30 | New Buy | 0.2% | $24.04 - $33.65 | $ 40.36 | 38% | 271100 | |
| George Soros | 2010-03-31 | Sold Out | $25.71 - $31.7 | $ 40.36 | 39% | 0 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 17.50 |
CBT's P/E(ttm) is ranked higher than
97% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 21.95 vs. CBT: 17.50 ) |
CBT'
s 10-Year P/E(ttm) Range
Min: 2.72 Max: 115.06 Current: 17.5 |
| P/S | 0.77 |
CBT's P/S is ranked higher than
56% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.80 vs. CBT: 0.77 ) |
CBT'
s 10-Year P/S Range
Min: 0.19 Max: 1.8 Current: 0.77 |
| PFCF | 74.74 |
CBT's PFCF is ranked higher than
56% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 17.30 vs. CBT: 74.74 ) |
CBT'
s 10-Year PFCF Range
Min: 2.12 Max: 122.08 Current: 74.74 |
| EV-to-EBIT | 15.72 |
CBT's EV-to-EBIT is ranked higher than
82% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 14.32 vs. CBT: 15.72 ) |
CBT'
s 10-Year EV-to-EBIT Range
Min: 4.5 Max: 54.7 Current: 15.72 |
| PEG | 0.53 |
CBT's PEG is ranked lower than
70% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.14 vs. CBT: 0.53 ) |
CBT'
s 10-Year PEG Range
Min: 0.39 Max: 12.96 Current: 0.53 |
| Shiller P/E | 17.31 |
CBT's Shiller P/E is ranked higher than
96% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 23.35 vs. CBT: 17.31 ) |
CBT'
s 10-Year Shiller P/E Range
Min: 9.37 Max: 50.39 Current: 17.31 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 1.98 |
CBT's Dividend Yield is ranked higher than
69% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.96 vs. CBT: 1.98 ) |
CBT'
s 10-Year Dividend Yield Range
Min: 1.14 Max: 8.83 Current: 1.98 |
| Dividend Payout | 0.1 |
CBT's Dividend Payout is ranked higher than
88% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.74 vs. CBT: 0.1 ) |
CBT'
s 10-Year Dividend Payout Range
Min: 0.07 Max: 0.54 Current: 0.1 |
| Dividend growth (3y) | 2 |
CBT's Dividend growth (3y) is ranked higher than
90% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.70 vs. CBT: 2 ) |
CBT'
s 10-Year Dividend growth (3y) Range
Min: 0 Max: 5.7 Current: 2 |
| Yield on cost (5-Year) | 2.34 |
CBT's Yield on cost (5-Year) is ranked higher than
70% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.96 vs. CBT: 2.34 ) |
CBT'
s 10-Year Yield on cost (5-Year) Range
Min: 1.27 Max: 9.84 Current: 2.34 |
| Share Buyback Rate | -0.1 |
CBT's Share Buyback Rate is ranked higher than
86% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: -0.75 vs. CBT: -0.1 ) |
CBT'
s 10-Year Share Buyback Rate Range
Min: 4.1 Max: -1.6 Current: -0.1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/DCF (Projected) | 1.1 | ||
| Price/Median PS Value | 0.8 |
CBT's Price/Median PS Value is ranked higher than
79% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.70 vs. CBT: 0.8 ) |
CBT'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 1.9 Current: 0.8 |
| Price/Peter Lynch Fair Value | 0.4 |
CBT's Price/Peter Lynch Fair Value is ranked lower than
70% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.40 vs. CBT: 0.4 ) |
CBT'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4 Max: 2.5 Current: 0.4 |
| Earnings Yield (Greenblatt) | 6.40 |
CBT's Earnings Yield (Greenblatt) is ranked higher than
87% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 6.05 vs. CBT: 6.40 ) |
CBT'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.8 Max: 22.1 Current: 6.4 |
| Forward Rate of Return (Yacktman) | 21.52 |
CBT's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.28 vs. CBT: 21.52 ) |
CBT'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: -21.4 Max: 35.5 Current: 21.52 |
| Industry: | Specialty Chemicals | |
|---|---|---|
| Compare: | NEU, SCL, VAL, POL, CYT | |
| Traded in other countries: | CBT.Germany |
| Ex-Div Reminder For SCBT Financial (SCBT) May 13 2013 - THESTREET |